Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.340 | GeneticVariation | disease | BEFREE | In conclusion, this study confirmed that SPAD is effective in eliminating albumin-bound as well as water-soluble toxins using a simulation of ALF. | 27121702 | 2017 | ||||
|
0.340 | GeneticVariation | disease | BEFREE | Multivariable analysis showed that a higher initial MELD-Na score (odds ratio [OR], 1.205; 95% confidence interval [CI], 1.018-1.427) and a lower initial serum albumin concentration (OR, 9.35; 95% CI, 1.15-76.9) were associated with increased odds of developing ALF. | 31777757 | 2019 | ||||
|
0.340 | Biomarker | disease | CTD_human | Recent advances in artificial liver support have used albumin as a binding and scavenging molecule in ALF. | 18609519 | 2008 | ||||
|
0.340 | Biomarker | disease | CTD_human | Lactate was increased and albumin was decreased in patients with acute liver failure compared to healthy controls resulting in normal net metabolic acid-base state. | 16750869 | 2006 | ||||
|
0.340 | Biomarker | disease | BEFREE | Absolute quantitation of acetaminophen-modified human serum albumin in acute liver failure patients by liquid chromatography/tandem mass spectrometry. | 29920820 | 2018 | ||||
|
0.340 | Biomarker | disease | BEFREE | To evaluate the effect of hepatocyte cyclooxygenase (COX)-2 in LPS-induced liver injury, we generated transgenic mice with targeted expression of COX-2 in the liver by using the albumin promoter-enhancer driven vector and the animals produced were subjected to a standard experimental protocol of LPS-induced acute fulminant hepatic failure (i.p. injection of low dose of LPS in combination with d-galactosamine (d-GalN)). | 19017995 | 2008 | ||||
|
0.340 | Therapeutic | disease | CTD_human | Lactate was increased and albumin was decreased in patients with acute liver failure compared to healthy controls resulting in normal net metabolic acid-base state. | 16750869 | 2006 | ||||
|
0.340 | Therapeutic | disease | CTD_human | Recent advances in artificial liver support have used albumin as a binding and scavenging molecule in ALF. | 18609519 | 2008 |